Komori
Governance4552JCR Pharmaceuticals Co.,Ltd.Pharmaceuticals

Independent Officer Notification Form

The independent officer notification was updated because a proposal for the election of outside officers will be submitted to the annual general meeting of shareholders on 23 June 2026. Asano Toshio (浅野敏雄) is listed as a newly appointed outside director.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit & Supervisory Board
Number of independent officers8Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

The scheduled date of change is 23 June 2026. Asano Toshio (浅野敏雄) is listed as a newly appointed outside director.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit & Supervisory Board
Number of independent officers8 people (5 outside directors and 3 outside audit & supervisory board members)
Changes this timeThe scheduled date of change is 23 June 2026. Asano Toshio (浅野敏雄) is listed as a newly appointed outside director.
Items this document does not state (5)
Number of directorsCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because proposals for the election of outside officers will be submitted to the Annual General Meeting of Shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | JCR Pharmaceuticals Co.,Ltd. (4552) timely disclosure | Komori